Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial direct current stimulation (tDCS)—a gentle, non-invasive technique that uses a small electrical current applied to the scalp—to see if it can help reduce depression symptoms in breast cancer patients undergoing chemotherapy. Many people with newly diagnosed breast cancer experience depression and stress, which can affect their recovery and quality of life. This study combines tDCS with supportive counseling to see if it helps patients feel better emotionally while they receive their cancer treatment.
Depression is very common in breast cancer patients and is linked to worse health outcomes and lower survival rates. Researchers want to find safe, effective ways to support patients' mental health during cancer treatment, and this non-medication approach using brain stimulation may offer a new option.
You likely qualify if…
You likely don't qualify if…
You would receive standard chemotherapy over repeated hospital stays (each cycle lasts 21 days). During each hospitalization, you would receive either real brain stimulation or a placebo version (a device that looks the same but delivers no current), combined with regular supportive counseling sessions with a staff member to help with emotional and psychological support. Throughout the study, researchers would monitor your depression symptoms, quality of life, and how well your cancer responds to treatment.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China